Orange Book product · Generic (ANDA)
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
At a glance
Aug 22, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 22, 2017
8 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
DESMOPRESSIN ACETATE
Strength
0.004MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 204751
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DESMOPRESSIN ACETATE
- 2026DESMODABrand (NDA)
NDA 219873 · ETON
- 2018NOCDURNABrand (NDA)
NDA 022517 · FERRING PHARMS INC
- 2017NOCTIVABrand (NDA)
NDA 201656 · ACERUS PHARMS
- 2008DESMOPRESSIN ACETATEBrand (NDA)
NDA 021795 · FERRING
- 2002MINIRINBrand (NDA)
NDA 021333 · FERRING
- 1995DDAVPBrand (NDA)
NDA 019955 · FERRING PHARMS INC
- 1994STIMATEBrand (NDA)
NDA 020355 · FERRING PHARMS INC
- 1990CONCENTRAIDBrand (NDA)
NDA 019776 · FERRING
- 1984DDAVPBrand (NDA)
NDA 018938 · NORDIC PHARMA
- —DDAVPBrand (NDA)
NDA 017922 · FERRING PHARMS INC
- 2026DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 219981 · CAPLIN
- 2024DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 213095 · AUROBINDO PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
